110814 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
MULTIVALENT VIRAL PARTICLES
#2Universal Influenza Vaccine and Methods of Use
#3SELF-AMPLIFYING MESSENGER RNA
#4Destroying Cancer Cells While Maintaining Healthy Cell Integrity
#5INFLUENZA VIRUS AND TYPE 1 DIABETES
#6Recombinant influenza virus-like particles (VLPS) produced in transgenic plants
#7High titer recombinant influenza viruses with enhanced replication in vero cells
#8INFLUENZA VIRUS AND TYPE 1 DIABETES
#9INFLUENZA TREATMENT AND/OR CHARACTERIZATION, HUMAN-ADAPTED HA POLYPEPTIDES; VACCINES
#10Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin
#11Engineered polypeptide agents for targeted broad spectrum influenza neutralization
#12Use of immune suppressive domains as medicaments
#13High titer recombinant influenza viruses with enhanced replication in vero cells
#14Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease
#15Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
#16Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
#17Engineered polypeptide agents for targeted broad spectrum influenza neutralization
#18High titer recombinant influenza viruses with enhanced replication in vero cells
#19RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ